Indoor Daylight Photodynamic Therapy is an Effective, First-line Treatment for AK, But Its Feasibility is Limited by the Time Required for the Illumination (2 Hours). Our Objective Was to Evaluate the Efficacy of Idl-PDT With an Illumination Time of 1 Hour Versus 2 Hours in the Treatment of Scalp AK
Clinical trial NCT07290959 · COMPLETED
Trial details
- NCT number
- NCT07290959
- Sponsor
- San Salvatore Hospital of L'Aquila
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-02
- Primary completion
- 2025-07-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.